1. Punyawudho B, Cloyd JC, Leppik IE, Ramsay RE, Marino SE, Pennell PB, White JR, Birnbaum AK (2009) Characterization of the time course of carbamazepine deinduction by an enzyme turnover model. Clin Pharmacokinet 48:313–320

   Article CAS PubMed PubMed Central Google Scholar

2. Cattaneo D, Giacomelli A, Casalini G, Ridolfo AL, Gervasoni C (2024) Management of enzyme de-induction in a woman with HIV on methadone maintenance switched from nevirapine- to bictegravir-based antiretroviral regimen. Eur J Clin Pharmacol 80:1105–1106

   Article CAS PubMed Google Scholar

3. Gazzard B, Moecklinghoff C, Hill A (2010) Nevirapine and enzyme induction: implications for drug–drug interactions. J Antimicrob Chemother 65:469–470

   Google Scholar

4. Reese MJ, Savina PM, Generaux GT et al (2013) Induction of drug metabolizing enzymes by nevirapine: implications for drug interactions. Clin Pharmacokinet 52:441–456

   Google Scholar

5. Eagling VA, Back DJ, Barry MG (1997) Differential induction of CYP3A4 and CYP2B6 by antiretrovirals in vitro. J Antimicrob Chemother 40:75–81

   Google Scholar

Download references